Lista de obras - Gregor Hoermann - Dominio Público Uruguay

A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body Composition

scientific article published on 21 February 2020

Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity.

artículo científico publicado en 2014

CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.

artículo científico publicado en 2016

CD52 is a molecular target in advanced systemic mastocytosis.

artículo científico publicado en 2014

CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance

artículo científico publicado en 2013

Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis.

artículo científico publicado en 2009

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

artículo científico publicado en 2014

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis

artículo científico publicado en 2021

Clonal hematopoiesis of indeterminate potential: clinical relevance of an incidental finding in liquid profiling

artículo científico publicado en 2022

Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice

artículo científico publicado en 2016

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms

artículo científico publicado en 2015

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

artículo científico publicado en 2016

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

artículo científico publicado en 2014

Endogenous erythroid colony formation in chronic myeloid leukemia: a recurrent finding associated with persistent minimal residual disease under imatinib.

artículo científico publicado en 2013

Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia

artículo científico publicado en 2017

Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.

artículo científico publicado en 2017

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H

artículo científico publicado en 2013

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.

artículo científico publicado en 2017

Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.

artículo científico publicado en 2015

Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients

artículo científico publicado en 2016

High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia.

artículo científico publicado en 2011

Homozygous familial hypercholesterolemia: Summarized case reports

artículo científico publicado en 2017

IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.

artículo científico publicado en 2016

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.

artículo científico publicado en 2015

Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progression

artículo científico publicado en 2012

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia

artículo científico publicado en 2015

Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.

artículo científico publicado en 2014

Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms

artículo científico publicado en 2011

Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis

artículo científico publicado en 2011

Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.

artículo científico publicado en 2015

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

artículo científico publicado en 2017

Interference of Mycoplasma Infection in a Gene Expression Study: It Was the Environment and Not the Gene ⬇️

artículo científico publicado el 1 de octubre de 2010

Interference of Mycoplasma Infection in a Gene Expression Study: It Was the Environment and Not the Gene.

artículo científico publicado en 2011

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

artículo científico publicado en 2015

KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib

artículo científico publicado en 2011

Lipoprotein(a) is not related to markers of insulin resistance in pregnancy.

artículo científico publicado en 2013

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

artículo científico publicado en 2015

Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives

scientific article published on 13 July 2018

NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors

artículo científico publicado en 2016

Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia

artículo científico publicado en 2013

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia

artículo científico publicado en 2012

PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis

artículo científico publicado en 2014

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis

scientific article published on 05 July 2018

Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells

artículo científico publicado en 2015

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib

artículo científico publicado en 2016

Serum-tryptase at diagnosis: a novel biomarker improving prognostication in Ph(+) CML.

artículo científico publicado en 2014

Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth

artículo científico publicado en 2016

The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

artículo científico publicado en 2014

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

artículo científico publicado en 2018

The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells

artículo científico publicado en 2015

The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils

artículo científico publicado en 2012

The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells

artículo científico publicado en 2021

The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells

artículo científico publicado en 2013

The tryptophan metabolite picolinic acid suppresses proliferation and metabolic activity of CD4+ T cells and inhibits c-Myc activation.

artículo científico publicado en 2015

Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors

artículo científico publicado en 2016

Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens.

artículo científico publicado en 2008

Lista de obras de Gregor Hoermann

A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body Composition

Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity.

CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.

CD52 is a molecular target in advanced systemic mastocytosis.

CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance

Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis.

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis

Clonal hematopoiesis of indeterminate potential: clinical relevance of an incidental finding in liquid profiling

Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

Endogenous erythroid colony formation in chronic myeloid leukemia: a recurrent finding associated with persistent minimal residual disease under imatinib.

Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia

Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.

Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.

Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients

High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia.

Homozygous familial hypercholesterolemia: Summarized case reports

IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.

Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progression

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia

Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.

Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms

Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis

Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

Interference of Mycoplasma Infection in a Gene Expression Study: It Was the Environment and Not the Gene ⬇️

Interference of Mycoplasma Infection in a Gene Expression Study: It Was the Environment and Not the Gene.

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib

Lipoprotein(a) is not related to markers of insulin resistance in pregnancy.

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives

NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors

Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia

PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis

Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib

Serum-tryptase at diagnosis: a novel biomarker improving prognostication in Ph(+) CML.

Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth

The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells

The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils

The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells

The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells

The tryptophan metabolite picolinic acid suppresses proliferation and metabolic activity of CD4+ T cells and inhibits c-Myc activation.

Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors

Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens.